AnteoTech Ltd (ASX: ADO) (“AnteoTech” or “the Company”) is pleased to announce the signing of a Distribution Agreement (Agreement) with Biomed Global Sdn. Bhd (Biomed) and its subsidiaries for the distribution of the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT).
20210719 AnteoTech Signs SE Asian Distribution Agreement for EuGeni
